ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,484Medicare Part D Prescriptions Filled, Including Refills

Rank: 213 out of 680

$511K Total Retail Price of All Prescriptions

Rank: 280 out of 680

279 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 5,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
ATORVASTATIN CALCIUM 378 177 1 11
LEVOTHYROXINE SODIUM 326 121 2 2
AMLODIPINE BESYLATE 324 227 3 1
OMEPRAZOLE 317 190 4 7
ALENDRONATE SODIUM 265 213 5 32
LIPITOR 265 90 5 68
LACTULOSE 258 35 7 92
SIMVASTATIN 247 227 8 3
LISINOPRIL 237 142 9 5
MELOXICAM 234 170 10 24
GABAPENTIN 209 122 11 15
PHENYTOIN SODIUM EXTENDED 208 30 12 115
HYDROCHLOROTHIAZIDE 208 152 12 9
FUROSEMIDE 190 145 14 6
METFORMIN HCL 190 95 14 8
SYNTHROID 188 129 16 38
METFORMIN HCL ER 183 123 17 54
CLONIDINE HCL 177 70 18 36
POTASSIUM CHLORIDE 145 107 19 14
KLOR-CON M20 144 73 20 61
GLIMEPIRIDE 143 95 21 29
PRENATAL PLUS 127 43 22 274
DOXAZOSIN MESYLATE 122 84 23 73
METOPROLOL SUCCINATE 115 60 24 13
NAPROXEN 114 47 25 121
NIFEDIPINE ER 112 88 26 75
METOPROLOL TARTRATE 108 91 27 12
BENAZEPRIL HCL 101 94 28 40
WARFARIN SODIUM 100 59 29 20
DIVALPROEX SODIUM 91 0 30 110
NEXIUM 90 66 31 16
CHLORHEXIDINE GLUCONATE 87 11 32 400
CARBAMAZEPINE 86 12 33 258
TAMSULOSIN HCL 79 37 34 34
VALPROIC ACID 77 12 35 254
LEVETIRACETAM 75 0 36 120
ZETIA 75 39 36 87
TRAZODONE HCL 74 0 38 48
CLOPIDOGREL 73 62 39 26
DIOVAN 73 36 39 31
LANTUS 72 44 41 49
DIGOXIN 66 62 42 58
KETOCONAZOLE 63 0 43 219
ATENOLOL 60 46 44 19
GUANFACINE HCL 59 0 R 45 281
NAMENDA 57 33 46 35
AMLODIPINE BESYLATE-BENAZEPRIL 57 29 46 43
DILTIAZEM 24HR ER 56 22 48 132
CELEBREX 54 14 49 90
CRESTOR 53 41 50 25
AMITRIPTYLINE HCL 52 39 R 51 47
MECLIZINE HCL 52 50 51 103
DONEPEZIL HCL 50 50 53 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.